Brief

The inspection of Alter Éco Santé's establishment in Villeneuve-Tolosane revealed significant non-conformities and shortcomings. Notified to the establishment on April 30, 2025, these issues were not resolved satisfactorily due to lack of defined and documented procedures for managing suppliers/subcontractors and quality deviations. The French National Agency for Medicine and Health Products Safety (ANSM) ordered Alter Éco Santé to rectify these issues within specified deadlines. The main purpose of the inspection was to ensure compliance with EU medical device regulations, specifically Article 10(9) of Regulation (EU) 2017/745. The inspection revealed a lack of procedures for managing suppliers/subcontractors and quality deviations, which led to non-compliance with EU regulations.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies